1-2 of 2
Priscilla A. Furth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Responsiveness of Brca1 and Trp53 Deficiency–Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus

Sahar J. Alothman, Weisheng Wang, David S. Goerlitz, Md Islam, Xiaogang Zhong, Archana Kishore, Redha I. Azhar, Bhaskar V. Kallakury, Priscilla A. Furth
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (4): 244–254.
https://doi.org/10.1158/1940-6207.CAPR-16-0268
Published: 02 April 2017
View article titled, Responsiveness of <em>Brca1</em> and <em>Trp53</em> Deficiency–Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in <em>Mus musculus</em>
Open the PDF for Responsiveness of <em>Brca1</em> and <em>Trp53</em> Deficiency–Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in <em>Mus musculus</em> in another window
Journal Articles

The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway

M. Carla Cabrera, Edgar S. Díaz-Cruz, Bhaskar V.S. Kallakury, Michael J. Pishvaian, Clinton J. Grubbs, Donald D. Muccio, Priscilla A. Furth
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (6): 810–821.
https://doi.org/10.1158/1940-6207.CAPR-11-0532-T
Published: 03 June 2012
View article titled, The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway
Open the PDF for The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated with Abnormal Activation of the Cyclin-CDK-Rb Pathway in another window
Includes: Supplementary data